An enzyme multiplied immunoassay technique is compared with a gas-liquid chromatographic technique for the measurement in blood serum of the anticonvulsants phenytoin, carbamazepine, phenobarbitone, primidone, and ethosuximide. The correlation between results obtained by each method was excellent, and both systematic and random errors were well within acceptable limits.
Although the value of measuring serum anticonvulsant levels is well established (Bajda et al., 1974; Kutt and Penry, 1974) , the equipment and procedures necessary for such measurements have been of continuing interest (Booker and Darcey, 1975; Spiehler et al., 1976) . Various methodologies have been developed for determining anticonvulsant drug levels in cerebrospinal fluid, blood, serum, and plasma. Quantitative drug levels can be measured by radioimmunoassay (RIA), spectophotometry, thin-layer chromatography (TLC), gas-liquid chromatography (GLC), and enzyme multiplied immunoassay technique (EMIT).
The first four procedures are time-consuming, require special handling procedures, or are subject to a variety of interfering substances. To date, GLC has been employed more often because of its specificity, sensitivity, and ability to be used for simultaneous drug analysis with a single sample. However, the preparation of a sample for GLC analysis is complex, time-consuming, and highly dependent upon the operator's skill. EMIT, in comparison, is the only method that seems to offer the advantage of speed, sensitivity, accuracy, and precision (Booker , and Darcey, 1975; Spiehler et al., 1976) . Moreover, the EMIT system does not show significant interference when challenged with extraordinarily high levels of cross-reacting drugs, gives results in less than 5 minutes, and is easy to operate. When the EMIT system is compared with GLC, it appears that it yields statistically equivalent phenytoin and phenobarbital drug levels (Booker and Darcey, 1975) . The purpose of the present study is to establish a correlation between EMIT and GLC measurements of serum primidone and carbamazepine as well as phenytoin and phenobarbital.
Material and methods
To evaluate the accuracy of EMIT measurement of serum anticonvulsants against the established GLC methodology, 30 control serum samples were measured, each containing unknown concentrations of five anticonvulsants (supplied by Columbia University). The concentration of each anticonvulsant present in each serum sample was measured in duplicate by EMIT and GLC independently. One averaged measurement each, from EMIT and GLC, was recorded and then compared to the exactly prepared control sample value for each drug present. Control sample values were received from Columbia University (Dr C. Pippenger) after all sample values had been recorded. Comparison of EMIT v control, GLC v control, and EMIT v GLC was made by regression analysis.
A Hewlett-Packard gas chromatograph model 5730A, equipped with dual hydrogen flame detectors and an automatic sampler and model 3380A Hewlett-Packard integrator, were used. Serum samples were analysed in duplicate by a modified Kupferberg gas-liquid chromatography procedure and likewise reported as a single value (Kupferberg, 1970 ).
The EMIT system used is composed of three integral parts which are coupled together to form a complete EMIT system. The equipment used in this study consisted of: (1) semiautomatic adjustable R. C. Berchou, R. A. Lodi and J. A. Sherman dilutor; (2) Stasar III microsample spectrophotometer; and (3) programmable printer calculator (Tektronix 31 +152).
STATISTICAL ANALYSIS
Statistical analysis was performed by using Michigan Interactive Data Analysis System (MIDAS) available through the statistical research laboratory of the University of Michigan. Errors were estimated by using the regression analysis parameters of slope, Y -intercept, and standard error of the estimate, according to methods suggested by Westgard and Hunt (1973) .
Through the method of Westgard and Hunt, an estimate of systemic and random error can be made. Systemic errors, such as a constant systematic error in recording concentration units or a proportional systematic error in the use of percentage units, may be reflected exactly in the intercept of the least squares regression line and by changes in the slope, respectively. Random error may be reflected in the magnitude of the standard error of the estimate. 
Results

PHENYTOIN
As can be seen from the Table and Fig. 1 , the slope of the regression line for EMIT against GLC is 1'001, indicating proportional error of 0·1 %. Con-stant error as estimated from the intercept is 0·007 rng/I. Random error is estimated at 1·42 mg/l from the standard error of the estimate (SE). The correlation coefficient is 0·990. From this analysis, for example, a value of 10 mg/l of phenytoin as measured by GLC would correspond to a value of 10·02 ± 1·42 (SD) mg/I by EMIT.
• Fig. 2 Comparison of measured phenobarbital levels,
EMIT v GLC.. r = 0,989, n = 24.
PHENOBARBlT AL As seen in Fig. 2 and According to the methods of Westgard and Hunt, estimates based on the least squares regression analysis of EMIT v GLC measurement of primidone ( Fig. 3 and Table) As can be seen from Fig. 5 and the mg/I,
Discussion
The results of this study indicate that EMIT gives an accurate measurement of serum anticonvulsant levels when compared with GLC. As seen from the Table, the lowest correlation coefficient of EMIT on GLC is 0'978, indicating an extremely good correlation. This relationship assumes added significance when it is considered that GLC measurement of anticonvulsant levels is usually taken as the standard of comparison.
Although the serum samples analysed in this study are ideal in that they do not contain substances that will interfere with the GLC or EMIT procedure, it appears that EMIT yields statistically equivalent result of phenytoin, phenobarbital, carbamazepine, and primodone levels in blood. To clarify further this relationship we are at present comparing serum and saliva measurements from patients taking various combinations of the above anticonvulsants. Preliminary data indicate excellent correlation between EMIT and GLC measurements of single saliva specimens obtained from patients on various combinations of anticonvulsants. Further studies of serum and saliva measurements and resulting ratios, we believe, will substantiate the applicability of the EMIT system's speed, sensitivity, accuracy, and precision.
